Compounds targeting the VEGF and/ or HIF pathway such as sorafenib or vatalanib for use in the treatment of otitis media

Details for Australian Patent Application No. 2011231405 (hide)

Owner Medical Research Council

Inventors Cheeseman, Michael T.; Brown, Steve D. M.

Agent Davies Collison Cave

Pub. Number AU-A-2011231405

PCT Pub. Number WO2011/117568

Priority 1004761.1 22.03.10 GB

Filing date 18 March 2011

Wipo publication date 29 September 2011

International Classifications

A61K 31/00

A61K 31/404

A61K 31/4412 - having oxo groups directly attached to the heterocyclic ring

A61K 31/502 - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 27/16 Drugs for disorders of the senses

Event Publications

4 October 2012 PCT application entered the National Phase

  PCT publication WO2011/117568 Priority application(s): WO2011/117568

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011231414-Zero shear viscosifying agent

2011231371-Consumable biscuit products and methods of production thereof